It's not just broker upgrades sending the CSL share price higher

The CSL Limited (ASX: CSL) share price has been on a tear in June.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The CSL Limited (ASX: CSL) share price hit a 6-month high of $212.84 today and it's not just because sell side research analysts at the likes of Goldman Sachs and Citigroup remain positive on the company.

Goldmans recently put a $223 12-month share price target on CSL shares that is probably encouraging investors to bid the stock higher given today's level is still around 5% below its target price. 

Another big factor likely supporting CSL is this week's resumption in the fall of the Australian dollar versus the U.S. dollar, with local jobs data today coming in weaker than expected in a result that has seen the Australian dollar fall towards multi-year lows against the greenback. 

This is actually good news for local CSL shareholders though as the company earns the majority of its revenues and profits in U.S. dollars, while reporting in U.S. dollars.

Therefore the lower the Australian dollar falls versus the U.S. dollar the more CSL's profits are worth to local shareholders.

Dividend payments for example are exchanged into Australian dollars for payment to local investors meaning as the Aussie dollar falls the value of the dividend payments rises inversely. 

It's also worth remembering it looks like the Australian dollar will be stuck in a sideways to down trend over the years ahead as analysts expect the Reserve Bank to keep cutting interest rates.

Of course this expectation is partly priced into currency exchange rates already, while CSL shares already trade on a big valuation as the currency outlook is no secret. 

However, for investors the local macro outlook means that buying companies with exposure away from the soft local economy and towards U.S. dollar earners probably still makes sense as a strategy. Share market investing is not rocket science and fortunately some of the best long-term growth companies in the healthcare space tick the boxes.

The likes of CSL, Cochlear Ltd (ASX: COH) and ResMed Inc. (ASX: RMD) are a lot more expensive than just 6 months and I'd strongly suggest they remain on investors' watch lists as high-quality local businesses.

Tom Richardson owns shares of Cochlear Ltd., CSL Ltd., and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares

Let’s see if they are bullish or bearish on these names.

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week this Monday.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

Paper aeroplane going down on a chart, symbolising a falling share price.
Travel Shares

Why Web Travel shares are sliding as fresh takeover hopes return

Web Travel shares sink as investors weigh CEO succession and takeover risk.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today

These shares are starting the week in the red. But why>

Read more »